A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment
Clinical trial NCT06105632 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06105632
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-09
- Primary completion
- 2026-01-12
- Enrollment
- 333
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.